Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.20M | 1.47M | 1.26M | 1.50M | 1.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20M | 1.47M | 1.26M | 1.50M | 1.21M |
| Cost of Revenue | 1.40M | 1.45M | 1.63M | 1.86M | 1.70M |
| Gross Profit | -201.00K | 29.00K | -369.00K | -356.00K | -486.00K |
| SG&A Expenses | 10.79M | 11.53M | 10.43M | 11.83M | 9.90M |
| Depreciation & Amortization | 105.00K | 105.00K | 105.00K | 105.00K | 105.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.48M | 14.28M | 13.37M | 15.52M | 12.97M |
| Operating Income | -12.28M | -12.80M | -12.11M | -14.01M | -11.76M |
| Income Before Tax | -6.68M | -11.69M | -13.91M | -16.27M | -10.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.68M | -11.69M | -13.91M | -16.27M | -10.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.68M | -11.69M | -13.91M | -16.27M | -10.40M |
| EBIT | -12.28M | -12.80M | -12.11M | -14.01M | -11.76M |
| EBITDA | -12.05M | -12.58M | -11.89M | -13.80M | -11.54M |
| EPS Basic | -0.04 | -0.08 | -0.17 | -0.12 | -0.10 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.05 | -0.07 | -0.07 |
| EPS Diluted | -0.04 | -0.08 | -0.17 | -0.12 | -0.10 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.05 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 190.94M | 183.12M | 140.10M | 131.39M | 108.18M |
| Average Diluted Shares Outstanding | 190.94M | 183.12M | 140.10M | 131.39M | 108.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |